BlossomHill Therapeutics Inc. Company Profile
NASDAQ: BLSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 16.88 0.00%
BlossomHill Therapeutics at a glance
BlossomHill Therapeutics Inc. (NASDAQ: BLSM) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Diego, CA. BlossomHill Therapeutics is led by Dr. Jingrong Jean Cui Ph.D. and employs about 69 people. The company's shares have traded publicly since 2026.
At a market capitalization of $527.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001839970, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does BlossomHill Therapeutics do?
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and BH-30236, a macrocyclic CLK (Cdc2-like kinase) inhibitor being evaluated in patients with relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndrome (HR-MDS). BlossomHill Therapeutics, Inc. was incorporated in 2020 and is based in San Diego, California.
Business description based on the company's public filings.
Company information
- Legal name
- BlossomHill Therapeutics Inc.
- Ticker
- NASDAQ: BLSM
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Jingrong Jean Cui Ph.D.
- Employees
- 69
- Headquarters
- 10255 Science Center Drive, San Diego, CA, United States
- Phone
- (858) 732-3880
- Website
- bhtherapeutics.com
- IPO year
- 2026
- Market cap
- $527.95M
- SEC CIK
- 0001839970
Companies similar to BlossomHill Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NGNENeurogene Inc. | 26.50 | +2.44% | $530.30M | vs BLSM |
| CBIOCrescent Biopharma Inc. | 14.12 | +4.67% | $524.51M | vs BLSM |
| OCSOculis Holding AG | 8.66 | +1.88% | $533.35M | vs BLSM |
| CTMXCytomX Therapeutics Inc. | 2.47 | -3.14% | $538.21M | vs BLSM |
| EOLSEvolus Inc. | 7.80 | +0.78% | $515.19M | vs BLSM |
| PBYIPuma Biotechnology Inc | 9.97 | +1.63% | $514.65M | vs BLSM |
| DRUGBright Minds Biosciences Inc. | 52.00 | 0.00% | $512.93M | vs BLSM |
| MPLTMapLight Therapeutics Inc. | 9.15 | -2.24% | $508.52M | vs BLSM |